# IVF Access

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ivf-access

- Industry: Healthcare
- Headquarters: Bangalore, India
- Website: www.ivfaccess.com
- Total disclosed funding: $5.9M
- Latest round: Series A (Jan 25, 2023)
- Investors on record: 1

## About

IVF Access is a reproductive health company offering advanced infertility treatments, specializing in In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI), while providing a supportive environment for couples seeking assistance with conception.IVF Access, founded in 2019, is based in Bangalore, India, and focuses on providing infertility treatments. The company raised USD 5.93 mn in Series A funding on January 25, 2023, from Vertex Ventures Southeast Asia & India, valuing the firm at USD 16.72 mn. The CEO is Naresh Rao, and the founder, Harinath Chakravarthy, has not been publicly noted for founding other companies.IVF Access specializes in advanced reproductive health services, particularly infertility treatments including In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI). The company operates modern fertility centers in Bengaluru, Hyderabad, and Coimbatore, offering services such as oocyte and embryo freezing, thus ensuring a supportive and private environment for couples. Their offerings cater to a wide range of clients seeking comprehensive fertility solutions, with a focus on high-quality embryo creation through controlled laboratory techniques.IVF Access generated revenue of USD 653,894.60 in 2023. The company's revenue model is based on a fee-for-service approach, where patients pay for specific treatments and consultations, including individual pricing for services like IUI and IVF, in addition to fees for oocyte and embryo freezing. This model allows for transparent pricing reflective of the treatment complexity, ensuring high standards of medical ethics and confidentiality.With the recent Series A funding of USD 5.93 mn raised in January 2023, IVF Access plans to expand its range of infertility treatments and enhance its service offerings. The funds will also support strategies to penetrate new geographic markets, with specific plans to increase its presence across India. The company aims to introduce innovative products and services in the near future, aligning with its mission to meet the evolving needs of patients seeking reproductive assistance.

## Funding rounds

- Series A, Jan 25, 2023, $5.9M — Vertex Ventures Southeast Asia & India

## Investors

- Vertex Ventures Southeast Asia & India (https://capitalatlas.ai/funds/vertex-ventures-southeast-asia-india) — Series A